FDA Inspection 1256486 — Nicolas Scheyer, MD
The FDA completed an inspection of Nicolas Scheyer, MD on Nov 21, 2024 in Vandouvre-Les-Nancy. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 21, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vandouvre-Les-Nancy (France)
Additional Details
Clinical Investigator (CI)